Stock Analysis
Illumina, Inc. (ILMN) Stock Analysis
Illumina, Inc. (ILMN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Illumina, Inc. (ILMN) currently has an AIQ Score of 49/100, indicating a neutral setup. Quality is the strongest factor at 78/100. Value is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
ILMN at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $206.45 |
| AIQ Score | 49/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Neutral |
| Market Cap | $31.34B |
| P/E Ratio | 41.18 |
| Forward P/E | — |
| EPS | $1.37 |
| Revenue TTM | $1.16B |
| Dividend Yield | 0.00% |
| Beta | 1.46 |
| Volume | 2.41M |
| 52-week range | $88.00-$231.81 |
| RSI 14 | 40.65 |
| 50-Day SMA | $200.30 |
| 200-Day SMA | $153.57 |
| Analyst Price Target | $188.20 |
| Next Earnings | Oct 29, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
ILMN
OverviewILMN Stock Analysis Summary
Illumina, Inc. (ILMN) currently has an AIQ Score of 49/100, indicating a neutral setup. Quality is the strongest factor at 78/100. Value is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, ILMN has AIQ Score of 49/100 with Quality base of 78/100 and fading Value at 26/100. Wait for component alignment before adding exposure.
Quality (78/100) leads while Value (26/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 2.57% stock move · ILMN classified in Medical - Diagnostics & Research.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is ILMN Bullish or Bearish Right Now?
ILMN currently has a neutral overall setup. Quality is the strongest factor at 78/100, while Value is weakest at 26/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 78/100.
- - Price is +3.07% above its 50-day SMA.
- - Value is the current constraint at 26/100.
- - Risk Resilience is weak at 41/100.
- - Analyst target implies -8.84% downside from the latest quote.
- - Technical consensus has more sell votes than buy votes (21 vs 18).
Current Consensus
ILMN's Technical Analysis Consensus is currently Neutral, with 18 buy, 6 neutral, and 21 sell votes. ILMN's 14-day RSI is 40.65, which places the stock in a weaker momentum range. ILMN's beta is 1.46, indicating greater market sensitivity than the broad market.
What Changed in ILMN?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the ILMN Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
ILMN Decision Framework
Public evidence layers, setup checks, and risk context for Illumina, Inc..
Illumina, Inc. (ILMN) Stock Analysis
Illumina, Inc. has an AIQ Score of 49/100 in a Neutral regime. Quality is strongest at 78/100. Beta is 1.46, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ILMN is in a Neutral AIQ regime with score 49/100. |
| Signal Conflict | The primary conflict is that quality leads at 78/100 while value lags at 26/100. |
| Factor Evidence | Momentum 46/100 · Value 26/100 · Quality 78/100 · Risk 41/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 78/100.
Momentum is 46/100 and RSI (14) is 40.6.
ILMN is in a Neutral regime at 49/100.
Risk factor is 41/100 with beta 1.46 and annual volatility 48.78%.
Current conflict: quality leads at 78/100 while value lags at 26/100.
ILMN Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
ILMN Fundamentals
ILMN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
ILMN Technical Analysis
ILMN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
ILMN Stock Catalysts
Track ILMN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
ILMN Dividend Analysis
ILMN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
ILMN Financial Data
ILMN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
ILMN Risk Analysis
ILMN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
ILMN Stock News
ILMN stock news, market tone, recent headlines, and catalyst context.
ILMN vs Life Sciences / Tools / CRO Peers
Current peer cohort: ILMN · LNTH · MEDP · NTRA · PRGO. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| ILMN Current stock | 49/100 | 26/100 | 46/100 | 41/100 | 1.74 | 48.78% | Current |
| LNTH Lantheus Holdings | 61/100 | 53/100 | 52/100 | 69/100 | 1.94 | 34.63% | ILMN vs LNTH |
| MEDP Medpace Holdings | 50/100 | 30/100 | 31/100 | 62/100 | 0.62 | 44.73% | ILMN vs MEDP |
| NTRA Natera | 50/100 | 34/100 | 52/100 | 64/100 | 1.54 | 47.94% | ILMN vs NTRA |
| PRGO Perrigo | 50/100 | 74/100 | 54/100 | 45/100 | -0.67 | 54.99% | ILMN vs PRGO |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 28, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching ILMN
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for ILMN
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
ILMN Stock FAQ
What is ILMN stock price today?
Illumina, Inc.'s current stock price is $206.45. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is ILMN bullish or bearish right now?
ILMN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is ILMN's market cap?
ILMN's market cap is $31.34B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is ILMN's current P/E ratio?
ILMN's current P/E ratio is 41.18 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is ILMN's RSI?
ILMN's 14-day RSI is 40.65 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is ILMN above its 50-day and 200-day moving averages?
ILMN is 3.07% from its 50-day SMA and 34.44% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is ILMN's next earnings date?
ILMN's next earnings date is currently listed as Oct 29, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does ILMN pay a dividend?
ILMN's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.